Literature DB >> 9176096

T-cell cytokines may control the balance of functionally distinct macrophage populations.

V J Tormey1, J Faul, C Leonard, C M Burke, A Dilmec, L W Poulter.   

Abstract

As monocytes differentiate into mature macrophages, subsets emerge that exhibit stimulatory, suppressive or phagocytic potential. These functionally distinct subsets can be discriminated using monoclonal antibodies RFD1 and RFD7. As examples of all these subsets have been repeatedly identified within the macrophage pool in a variety of organs the overall functional capacity of this pool will depend on the relative balance of these subpopulations. This study investigates whether this balance present in mature macrophage populations can be regulated by the local influence of T-cell-derived cytokines. The dose-dependent effect of cytokines interferon-gamma (IFN-gamma), interleukins (IL) IL-2, IL-4 and IL-10 on the phenotype and function of monocyte-derived macrophages was determined. Subsets of mature cells were quantified by identifying RFD1- RFD7- stimulatory cells (D1+); RFD1- RFD7+ phagocytes (D7+) and RFD1+ RFD7+ suppressive cells (D1 D7+). IFN-gamma and IL-4 increased the relative proportions of D1+ stimulatory cells and upregulated HLA-DR expression. IFN-gamma also increased the capacity of the mature macrophage pool to stimulate T-cell proliferation. IL-10 reduced the proportions of D1+ stimulatory cells while promoting the differentiation of D7+ phagocytes and D1/D7+ suppressive cells. IL-10 induced changes also reduced the functional capacity of the mature populations to stimulate T cells in auto and allogenic mixed lymphocyte reactions (MLR). IL-2 had no effect on differentiation of monocytes. Thus IL-4 and IFN-gamma are seen to induce the development of stimulatory macrophages while IL-10 promotes differentiation of monocytes to mature phagocytes and suppressive macrophages. It is concluded that mature macrophage phenotype is 'plastic' and under the control of T-cell-derived mediators. Furthermore, within the differentiating monocytes, phenotypic change appears to carry with it functional change, thus retaining the relationship between antigen expression and activity in the mature macrophage populations.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9176096      PMCID: PMC1456681          DOI: 10.1046/j.1365-2567.1997.00207.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  36 in total

1.  Regulation of T helper cell responses in experimental murine schistosomiasis by IL-10. Effect on expression of B7 and B7-2 costimulatory molecules by macrophages.

Authors:  P O Flores Villanueva; H Reiser; M J Stadecker
Journal:  J Immunol       Date:  1994-12-01       Impact factor: 5.422

2.  Monoclonal antibody EBM/11: high cellular specificity for human macrophages.

Authors:  P M Kelly; E Bliss; J A Morton; J Burns; J O McGee
Journal:  J Clin Pathol       Date:  1988-05       Impact factor: 3.411

3.  Dendritic cells and scavenger macrophages in chronic inflammatory bowel disease.

Authors:  C A Seldenrijk; H A Drexhage; S G Meuwissen; S T Pals; C J Meijer
Journal:  Gut       Date:  1989-04       Impact factor: 23.059

4.  Discrimination of human macrophages and dendritic cells by means of monoclonal antibodies.

Authors:  L W Poulter; D A Campbell; C Munro; G Janossy
Journal:  Scand J Immunol       Date:  1986-09       Impact factor: 3.487

Review 5.  The role of alveolar macrophages in regulation of lung inflammation.

Authors:  T Thepen; G Kraal; P G Holt
Journal:  Ann N Y Acad Sci       Date:  1994-05-28       Impact factor: 5.691

Review 6.  Immunological/physiological relationships in asthma: potential regulation by lung macrophages.

Authors:  L W Poulter; G Janossy; C Power; S Sreenan; C Burke
Journal:  Immunol Today       Date:  1994-06

7.  The accessory cell function of human alveolar macrophages in specific T cell proliferation.

Authors:  G B Toews; W C Vial; M M Dunn; P Guzzetta; G Nunez; P Stastny; M F Lipscomb
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

8.  Influence of 1,25-(OH)2 vitamin D3 and gamma interferon on the phenotype of human peripheral blood monocyte-derived macrophages.

Authors:  L W Poulter; G A Rook; J Steele; A Condez
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

9.  The density of HLA-DR antigen expression on alveolar macrophages is increased in pulmonary sarcoidosis.

Authors:  D A Campbell; R M du Bois; R G Butcher; L W Poulter
Journal:  Clin Exp Immunol       Date:  1986-07       Impact factor: 4.330

10.  Interleukin 10 blocks HIV replication in macrophages by inhibiting the autocrine loop of tumor necrosis factor alpha and interleukin 6 induction of virus.

Authors:  D Weissman; G Poli; A S Fauci
Journal:  AIDS Res Hum Retroviruses       Date:  1994-10       Impact factor: 2.205

View more
  11 in total

1.  Elevated major histocompatibility complex class I expression protects T cells from antibody- and macrophage-mediated deletion.

Authors:  T Orlikowsky; Z Wang; A Dudhane; R Mittler; V Trejo; G E Dannecker; D Niethammer; M K Hoffmann
Journal:  Immunology       Date:  1998-11       Impact factor: 7.397

2.  Iron overload and heart fibrosis in mice deficient for both beta2-microglobulin and Rag1.

Authors:  M M Santos; M de Sousa; L H Rademakers; H Clevers; J J Marx; M W Schilham
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

3.  Immunologic effector mechanisms of a standardized mistletoe extract on the function of human monocytes and lymphocytes in vitro, ex vivo, and in vivo.

Authors:  Lucie Heinzerling; Volker von Baehr; Christa Liebenthal; Rüdiger von Baehr; Hans-Dieter Volk
Journal:  J Clin Immunol       Date:  2006-05-17       Impact factor: 8.317

4.  Fluticasone propionate-induced regulation of the balance within macrophage subpopulations.

Authors:  V J Tormey; S Bernard; K Ivory; C M Burke; L W Poulter
Journal:  Clin Exp Immunol       Date:  2000-01       Impact factor: 4.330

5.  Combined treatment with bevacizumab and standard chemotherapy restores abnormal immune parameters in advanced colorectal cancer patients.

Authors:  Nikolaos Tsavaris; Ioannis F Voutsas; Christos Kosmas; Angelos D Gritzapis; Constantin N Baxevanis
Journal:  Invest New Drugs       Date:  2010-09-07       Impact factor: 3.850

6.  Monocyte-macrophage ferric reductase activity is inhibited by iron and stimulated by cellular differentiation.

Authors:  J Partridge; D F Wallace; K B Raja; J S Dooley; A P Walker
Journal:  Biochem J       Date:  1998-12-15       Impact factor: 3.857

7.  Differentiation of C2D macrophage cells after adoptive transfer.

Authors:  Betsey E Potts; Marcia L Hart; Laura L Snyder; Dan Boyle; Derek A Mosier; Stephen K Chapes
Journal:  Clin Vaccine Immunol       Date:  2007-12-19

8.  Normal human dermis contains distinct populations of CD11c+BDCA-1+ dendritic cells and CD163+FXIIIA+ macrophages.

Authors:  Lisa C Zaba; Judilyn Fuentes-Duculan; Ralph M Steinman; James G Krueger; Michelle A Lowes
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

Review 9.  Macrophage roles following myocardial infarction.

Authors:  Jessica M Lambert; Elizabeth F Lopez; Merry L Lindsey
Journal:  Int J Cardiol       Date:  2008-07-25       Impact factor: 4.164

Review 10.  Studies using the anti-idiotypic monoclonal antibody 105AD7 in patients with primary and advanced colorectal cancer.

Authors:  Charles Maxwell-Armstrong
Journal:  Ann R Coll Surg Engl       Date:  2002-09       Impact factor: 1.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.